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Abstract
Background—Environmental contaminants that disrupt endocrine function may contribute to
hypospadias etiology.
Objective—To compare levels of selected halogenated organic pollutants in women delivering
infants with and without hypospadias.
Methods—This study examined levels of nine polybrominated flame retardants (PBDEs), 30
polychlorinated biphenyls (PCBs) and nine persistent pesticides in mid-pregnancy serum samples
from 20 women who delivered infants with hypospadias and 28 women who delivered unaffected
infants, in California. Analytes were measured using isotope dilution high-resolution mass
spectrometry. Values below individual limits of detection (LOD) for each analyte were imputed
based on a truncated multivariate normal distribution. Levels of 17 analytes for which at least 50%
of cases and controls had values above the LOD were compared using t-tests and by generating odds
ratios from logistic regression analyses.
Results—Means were greater for cases than controls for 11 of the 17 reported analytes (4 of 5
PBDEs, 7 of 9 PCBs, and 0 of 3 other persistent pesticides), but none of the differences were
statistically significant. Eleven of the 17 odds ratios exceeded one (the same analytes that had greater
means), but none of the confidence intervals excluded one. After adjustment for sample processing
time and foreign-born Hispanic race-ethnicity, only four of the odds ratios exceeded one.
Conclusions—Levels of the PBDEs and PCBs were not statistically significantly different, but
the sample size was small. The current study adds to a relatively limited knowledge base regarding
the potential association of specific contaminants with hypospadias or other birth defects.
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INTRODUCTION
Halogenated organic pollutants are ubiquitous in the environment. Concerns about their
potential for harmful effects on human health abound and include various disruptions to the
endocrine system. Concerns have led to bans on the use of many of them. For example, the
pesticide p,p′-dichlorodiphenyltrichloroethane (DDT) and its metabolite p,p′-
dichlorodiphenyldichloroethylene (DDE), as well as polychlorinated biphenyls (PCBs), were
used industrially and had multiple uses. DDT and PCBs were banned in the 1970s. More
recently, concerns have arisen regarding polybrominated diphenyl ethers (PBDEs), which are
widely used as flame retardants (e.g., in the padding under wall-to-wall carpeting and the hard
plastic casings of electronic equipment). PBDE use may currently be declining, due to
voluntary suspension of production of penta-and octa-BDE mixtures [Great Lakes Chemical
Corporation, 2003; Harrad and Diamond, 2006]. Nevertheless, human exposures to all of these
contaminants continue because of their environmental persistence and long half-lives.
Hypospadias, a congenital malformation in which the urethral opening is on the ventral side
of the penis, is one of the most common congenital malformations, affecting four to six males
per 1,000 male births [Paulozzi et al., 1997; Paulozzi, 1999; Dolk et al., 2004]. Normal urethral
closure, which occurs during the 7th–15th weeks of pregnancy (i.e., weeks after the last
menstrual period) [Sadler, 2004], depends on fetal conversion of testosterone to
dihydrotestosterone, binding of dihydrotestosterone to the androgen receptor, and proper
subsequent androgen receptor signaling. Given the importance of endocrine function to
urogenital development, it has been proposed that environmental contaminants that disrupt
endocrine function may contribute to hypospadias etiology.
Hypospadias can be induced experimentally by administration of several anti-androgenic
pesticides, including vinclozolin, prochloraz and procymidone [Gray, Jr. et al., 2004; Noriega
et al., 2005; Ostby et al., 1999]. A few human studies have attempted to assess the association
between environmental contaminants and hypospadias. Most of these studies had limited
exposure assessment (e.g., self-reported occupation), time windows of exposure that were not
specific to urethral development, and/or case information that was passively reported {Pierik,
2004 1504/id; Weidner, 1998 951/id; Kristensen, 1997 481/id; Carbone, 2006 2126/id; Olshan,
1991 2127/id; Zhu, 2006 2128/id; Ormond, 2009 2474/id}. Three studies have measured
maternal levels of DDE, which has known estrogenic and anti-androgenic properties, in
populations with relatively high exposure [Bhatia et al., 2005; Longnecker et al., 2002; Flores-
Luevano et al., 2003]. The odds ratios comparing high versus low values in these studies were
1.2 (95% confidence interval (CI) 0.6, 2.4) [Longnecker et al., 2002], 1.2 (0.5, 3.0) [Bhatia et
al., 2005], and 0.5 (0.2, 1.6)[Flores-Luevano et al., 2003]. One study examined maternal serum
PCBs and found that levels of individual congeners were not associated with hypospadias.
Other studies observed that maternal serum PCB levels during pregnancy {McGlynn, 2009
2473/id} and historical maternal exposure to polybrominated biphenyl {Small, 2009 2475/id}
were not associated with hypospadias.
The current study examined serum levels of selected potentially endocrine-disrupting
environmental contaminants – PBDEs, PCBs, and several other persistent pesticides, including
DDT and DDE – in routinely collected mid-pregnancy serum samples from women who
delivered infants with and without hypospadias. The objective of the study was to compare
levels of the contaminants in a small group of women delivering infants with and without
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hypospadias. Our hypothesis was that these chemicals may affect fetal urogenital development
by disrupting fetal endocrine function, by directly targeting the fetus or indirectly by targeting
the placenta, which is integral to fetal endocrine function.
METHODS
This study examined mid-pregnancy serum samples from women in California. Specimens
were collected from most women (70%) during the 15th–18th week of pregnancy, in southern
California (primarily Orange and San Diego counties) [Shaw et al., 2009]. Specimens were
collected as part of the California Expanded AFP (alpha-feto-protein) program that screens for
neural tube defects and cytogenetic abnormalities. The collection and processing of specimens
was as follows: 1) samples were taken at draw stations using BD™ Vacutainer 3.5 mL serum
separator tubes with no anticoagulants or preservatives and centrifuged; 2) samples were
received by designated clinical laboratories from draw stations at room temperature, on average
3.0 days after draw; 3) AFP assays were run on samples usually on the day received; 4) samples
were refrigerated up to 7 days, in case further testing was necessary; 5) samples were sent on
cold packs via overnight mail to the serum storage bank; and 6) samples were aliquoted, labeled
with barcodes, and frozen at −70° C.
Each woman’s serum specimen was linked with delivery outcome information to determine
whether her fetus had a structural malformation, which was determined via medical record
review by the California Birth Defects Monitoring Program [Shaw et al., 2009].
Among the more than 100,000 pregnancy specimens collected for testing in 2003 and that
resulted in a liveborn delivery in 2003, we identified 63 cases with hypospadias. Among the
29 cases for which two serum specimens were available, we selected all 16 for whom the degree
of severity was not specified and the four that were coronal, to give a total of 20 cases. As
controls, we randomly selected 28 specimens that were collected at the same lab during the
same time period and corresponded to non-malformed, liveborn male infants delivered in 2003.
Thus, this was a nested case-control study. The selection of samples was limited to singletons.
All samples were obtained with approval from the California Health and Welfare Agency
Committee for the Protection of Human Subjects.
Specimens for the 48 subjects were sent on cold packs to the Centers for Disease Control and
Prevention (CDC) for measurement in 2006. The serum samples were extracted by solid phase
extraction (SPE) and after lipid removal analyzed by GC-IDHRMS (isotope dilution high-
resolution mass spectrometry). The final analytic results were reported as fresh weight
concentration (pg/mL serum) and lipid-adjusted concentration (ng/g lipid) [Sjodin et al.,
2004b]. The measured analytes included nine polybrominated flame retardants (PBDEs), 30
polychlorinated biphenyls (PCBs) and nine persistent pesticides.
The limit of detection (LOD) was sample-specific, based on the sample volume. Values that
were below the LOD were imputed based on a truncated multivariate normal distribution. This
approach allowed us to incorporate information on correlations between related analytes and
to restrict imputed values to being below the individual’s LOD for each particular analyte. This
type of imputation approach using truncated normal distributions has been applied previously
in numerous settings [Lubin et al., 2004; Uh et al., 2008].
A priori, we restricted comparisons of levels of the analytes among cases versus controls to
analytes for which at least 50% of cases and controls had values above the LOD, i.e., 5 of 9
PBDEs, 9 of 30 PCBs, and 3 of 9 persistent pesticides. DDE had no values below the LOD
and was therefore analyzed without multiple imputation. The distributions of the analytes
(quartiles and means) were described based on considering the five imputed datasets as a single
dataset. We examined the association of each analyte with case-control status by examining t-
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tests for differences in the means, and by using logistic regression to estimate odds ratios (OR)
and 95 percent confidence intervals (CI), using SAS PROC MIANALYZE (SAS 9.1, Cary,
NC). We considered the following covariates for inclusion in the logistic regression analyses:
maternal race-ethnicity (non-Hispanic white, U.S.-born Hispanic, foreign-born Hispanic,
other); education (<, =, > high school); age (<35 years, versus 35 or older); number of previous
live births (none versus any); time elapsed between blood collection and AFP analysis (i.e.,
time at room temperature); and time elapsed between AFP analysis and storage in the serum
bank at −70° C (i.e., time under refrigeration). Two of these factors had an association with
case-control status, based on univariate logistic regression analyses: foreign-born Hispanic
race-ethnicity (OR 0.13, 95% CI 0.02, 1.2 for foreign-born Hispanic versus non-Hispanic white
race-ethnicity, p-value 0.067) and time lapsed between blood collection and AFP analysis (OR
for a one-day change was 0.6, 95% CI 0.3, 1.1, p-value 0.084); p-values for the other variables
were all >0.1. Therefore, we considered incorporation of these two variables into the logistic
regression analyses, as potential confounders.
RESULTS
Mean sample weights after removal of 250 μl for lipid analysis were 0.72 g (SD 0.17, range
0.33–1.01) among cases and 0.75 g (SD 0.10, range 0.49–0.93) among controls. Descriptive
characteristics of study subjects are shown in Table 1. Mothers of cases were more likely to
have higher education and be nulliparous and less likely to be Hispanic, and case infants were
more likely to be low birthweight. The distribution of the analytes and percent of samples
imputed are shown in Table 2.
Mean time elapsed between blood collection and AFP analysis was 2.9 days (SD 0.9) among
cases and 3.5 (SD 1.2) among controls. Mean time elapsed between AFP analysis and storage
at −70°C was 13.0 days (SD 2.0) among cases and 12.9 (SD 1.4) among controls. Among the
controls, correlations of the studied analytes with time elapsed between sample collection and
AFP testing were negative (ranging from −0.37 to −0.06), except for DDT and DDE (0.09 and
0.08, respectively) (data not shown). The confidence intervals for the coefficients all included
one. Correlations of the analytes with time elapsed between AFP testing and storage at −70°
C were more variable (ranging from −0.36 to 0.22), and all confidence intervals included one.
In comparisons of analyte levels among the cases and controls, means were greater for cases
than controls for 11 of the 17 reported analytes (4 of 5 PBDEs, 7 of 9 PCBs, and 0 of 3 other
persistent pesticides), but none of the differences were statistically significant (Table 2).
Medians were greater for cases than controls for 9 of the 17 analytes. Eleven of the 17 odds
ratios exceeded one (the same analytes that had greater means), but none of the confidence
intervals excluded one (Table 3). After adjustment for foreign-born Hispanic race-ethnicity
and time elapsed between sample collection and AFP analysis, confidence intervals still
excluded one, but only four of the odds ratios exceeded one.
Imputing values below the LOD as the median LOD for a particular analyte divided by the
square root of two did not result in a different pattern of results (data not shown).
DISCUSSION
This study examined whether levels of several environmental contaminants differed between
hypospadias cases and non-malformed controls. The pattern of results suggested higher levels
of PBDEs and PCBs among cases than controls (means were greater for cases and odds ratios
exceeded one for four of five PBDEs and seven of nine PCBs), but after adjustment for potential
confounders, this was not true. None of the comparisons were statistically significant.
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Hypospadias is considered part of the testicular dysgenesis syndrome, which comprises several
reproductive tract abnormalities – hypospadias, cryptorchidism, testicular germ cell cancer and
impaired spermatogenesis – that may share a common etiology resulting from impairment in
endocrine function during fetal development [Sharpe and Skakkebaek, 2008]. Accordingly, it
has been proposed that these outcomes may be associated with many of the studied
contaminants, given that PCBs and the other studied persistent pesticides have known effects
on androgen-dependent reproductive health outcomes [Gray, Jr. et al., 2004; Cooke et al.,
2001], and evidence for similar effects of PBDEs is accumulating [Legler and Brouwer,
2003; Stoker et al., 2005]. One recent study suggested increased risk of cryptorchidism was
associated with higher maternal breast milk levels of PBDEs [Main et al., 2007]. In general,
however, results of studies examining potentially endocrine-disrupting chemicals and male
reproductive health outcomes are equivocal [Vidaeff and Sever, 2005].
Few studies have examined the association of hypospadias with any of the analytes considered
in the current analysis. Two studies examined DDE and PCBs and included third trimester
maternal serum samples from women enrolled from 1959–1965, a time when levels were much
higher than today {McGlynn, 2009 2473/id}{Longnecker, 2002 960/id}. One study examined
DDE and DDT and included serum samples that were primarily obtained soon after delivery,
for deliveries from 1959–1967 {Bhatia, 2005 1346/id}. Another study of DDE, DDT and beta-
hexachlorobenzene included serum samples obtained on average more than five years after
delivery, among women in Mexico {Flores-Luevano, 2003 2334/id}. Maternal exposure to
polybrominated biphenyl (congener 153) in the 1970s was measured many years before
pregnancy by a study that included male offspring with genitourinary conditions, including
five cases with hypospadias cases {Small, 2009 2475/id}. None of the studies found strong
associations with hypospadias, although an interesting finding by McGlynn et al. was a
potential association of hypospadias with the sum of PCBs {McGlynn, 2009 2473/id}. Thus,
the literature includes studies that are not particularly comparable with regard to time period
or geography, and none collected specimens at the time of urogenital development. Also, none
of them had information regarding the location of the urethral meatus.
Although the current study is limited by its small sample size, it is strengthened by its inclusion
of specimens from early pregnancy and its timeliness. Other strengths include the prospective
study design; utilization of laboratory techniques that enabled detection of low levels of
multiple analytes in a relatively small sample volume; and the multiple imputation approach
to estimation of analyte levels below the limit of detection. Limitations included the small
number of subjects, low sample volume, and unspecified location of the urethral meatus in
most of the selected cases. In particular, a new study with 20 cases and 28 controls would have
80% power using a type 1 error rate of 5% to detect a 0.82 SD difference in exposure levels
between cases and controls. Budgetary restrictions and sample availability restricted our ability
to examine more subjects. Although the number of subjects was small – and thus the study was
exploratory – it is noteworthy that some expected differences were observed between cases
and controls, including fewer of the mothers of cases being Hispanic, more of the mothers of
cases having higher education and being nulliparous, and more of the cases being low
birthweight, relative to the controls [Carmichael et al., 2003; Carmichael et al., 2007]. Given
the dearth of comparable data in the literature, a small-scale study seemed like a prudent first
step toward understanding exposure levels in the study population and their association with
hypospadias. Low sample volume resulted in a reliance on imputed data, which could lead to
spurious results. The sample collection parameters also limited what compounds we could
measure; for example, other potentially endocrine-disrupting contaminants, such as phthalates,
bisphenol-A and other more volatile compounds, were not measurable. In addition, given the
limited sample size and lack of association with individual compounds, we did not explore
mixtures of compounds based on their known functions (e.g., examining analytes with known
estrogenic effects as a single group), although this may be an important area of future inquiry
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[Sharpe and Skakkebaek, 2008; Bloom et al., 2007; Rider et al., 2009]. We also were unable
to examine genetic variability in biotransformation of halogenated organics and end-organ
susceptibility, which would be an important consideration for future studies. Sample collection
during mid-pregnancy was a strength (e.g., versus at delivery or post-partum), but nevertheless
it occurred at the end of or shortly after completion of the urethral closure process. Given the
persistence of the studied compounds, however, the levels are likely to be a good reflection of
at least the few preceding weeks.
A benefit of this study is that it establishes the feasibility of measuring the selected analytes
under the given sample collection and handling conditions. Although sample volume was
limited, it was adequate to allow detection of reasonable levels of many of the analytes in most
samples. A potential concern was contamination of the samples with ambient PBDEs (e.g.,
from dust). However, the median ratio of PBDE-99 to PBDE-47 was 0.31 among cases and
0.32 among controls, which is consistent with previous studies and suggests that substantial
contamination did not occur during sample processing (exogenous PBDEs tend to have a higher
ratio) [Bradman et al., 2007; Sjodin et al., 1998; Sjodin et al., 2005]. Also consistent with other
studies, the correlations of PBDEs with PCBs were low (e.g., among controls, the correlation
of PBDE-47 with PCB-153 was 0.05) and support the idea that exposure pathways differ for
the two classes of compounds [Bradman et al., 2007; Schecter et al., 2006].
This study also documents baseline levels in the study population, albeit in a relatively small
group. Table 4 shows levels of some of the analytes observed in other recent study populations
for comparison. Few previous studies have examined levels during pregnancy, especially in
the U.S. Most have been limited to relatively small sample sizes and tend to include fewer
individual compounds or classes of compounds than the current study. Median levels of PBDEs
in our study were comparable to levels observed by NHANES among U.S. females [Sjodin et
al., 2008] and levels among pregnant women in a small study in Indiana [Mazdai et al.,
2003]. Most levels were at least two-fold higher than levels among pregnant women in another
California study [Bradman et al., 2007], and most were many-fold higher than levels among
pregnant women in Sweden [Guvenius et al., 2003]. In contrast, PCBs in our study tended to
be lower than in the other studies, although PCB-153 was about 2-fold higher in our study than
in the other California study [Bradman et al., 2007]. As for the other persistent pesticides, our
study had lower levels than another study of pregnant women in California [Fenster et al.,
2006] and levels that were more similar to a study of pregnant women in New York [Wolff et
al., 2005]. Explanations for the differences are unknown. It is noteworthy that most of the
women in the other California studies were Mexican immigrants, residing in central California,
which may account for some of the differences in exposures with our study.
CONCLUSIONS
Current knowledge regarding the potential effects of the studied compounds on infant health
– especially birth defects – is limited. Although the current study had certain limitations, it
does add to our knowledge regarding exposure to the selected contaminants among pregnant
women and regarding potential associations with hypospadias. Based on this study, in
conjunction with the few other available studies, it appears that if the analytes we examined
are associated with hypospadias, the associations with individual compounds may be small.
Confirmation by larger studies of more contemporaneous groups of subjects is needed.
Examining exposure to combinations of compounds – whether within classes of compounds
or across classes, especially those that may have similar endocrine effects – is also important
to explore in the future.
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Table 1




 Hispanic – U.S.-born 5 (1) 21 (6)
 Hispanic – foreign-born 5 (1) 29 (8)
 Non-Hispanic white 50 (10) 32 (9)
 Other 40 (8) 18 (5)
Age (years)
 <25 15 (3) 25 (7)
 25–34 70 (14) 61 (17)
 35 or greater 15 (3) 14 (4)
Education
 < 12 years 10 (2) 29 (8)
 = 12 years 25 (5) 21 (6)
 > 12 years 60 (12) 46 (13)
Number of previous live births
 0 50 (10) 43 (12)
 1 or more 50 (10) 57 (16)
Birth weight
 <2500 gm 25 (4) 0 (0)
 2500 gm or more 75 (16) 100 (28)
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Table 3
Association of maternal mid-pregnancy levels of analytes with risk of hypospadias among offspring.
Analytes (ng/g lipid)
Crude Adjusted
Odds Ratio p-value Odds Ratioc p-value
Brominated Flame Retardants
 PBDE-28a 1.05 (0.78, 1.42) 0.73 0.95 (0.68, 1.31) 0.74
 PBDE-47b 1.04 (0.94, 1.14) 0.44 1.01 (0.93, 1.11) 0.73
 PBDE-99b 1.10 (0.87, 1.38) 0.44 1.06 (0.90, 1.22) 0.50
 PBDE-100b 1.08 (0.79, 1.47) 0.63 1.02 (0.74, 1.35) 0.90
 PBDE-153b 0.99 (0.71, 25.03) 0.96 0.95 (0.67, 1.35) 0.76
Polychlorinated Biphenyls
 PCB-52a 1.07 (0.77, 1.48) 0.69 1.04 (0.74, 1.48) 0.80
 PCB-99a 1.10 (0.79, 1.54) 0.56 1.00 (0.70, 1.42) 0.99
 PCB-153b 1.39 (0.54, 3.53) 0.49 0.84 (0.30, 2.46) 0.72
 PCB-180b 1.05 (0.39, 2.82) 0.91 0.66 (0.22, 2.01) 0.46
 PCB-187a 1.02 (0.82, 1.25) 0.88 0.95 (0.76, 1.19) 0.63
 PCB-194a 1.03 (0.81, 1.31) 0.80 0.93 (0.71, 1.21) 0.58
 PCB-199a 0.98 (0.74, 1.29) 0.87 0.90 (0.66, 1.22) 0.47
 PCB-138_158b 0.83 (0.32, 2.15) 0.70 0.61 (0.22, 1.65) 0.33
 PCB-196_203a 1.03 (0.82, 1.30) 0.77 0.97 (0.76, 1.23) 0.78
Other Persistent Pesticides
 Hexachlorobenzenea 0.92 (0.80, 1.05) 0.21 0.95 (0.79, 1.13) 0.53
 p,p′-DDTa 1.00 (0.99, 1.00) 0.70 1.00 (0.99, 1.01) 0.72
 p,p′-DDEb 1.00 (0.99, 1.00) 0.59 1.00 (0.95, 1.00) 0.80
a
OR for a 1 ng/g lipid change in the analyte (presented for analytes with an interquartile range spanning <5 ng/g lipid, as shown in Table 1).
b
OR for a 10 ng/g lipid change in the analyte (presented for analytes with an interquartile range spanning ≥5 ng/g lipid, as shown in Table 1).
c
ORs adjusted by sample processing time and foreign-born Hispanic race-ethnicity.
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